In a Phase 3 trial, Tezspire put most eosinophilic esophagitis patients in tissue remission at one year. What does it mean for swallowing and approval?
Nearly Two in Three Eosinophilic Esophagitis Patients on Tezspire Reached Tissue Remission After One Year of Treatment
by | Oct 21, 2026 | Uncategorized | 0 comments
Recent Comments